English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Mark D. Gonzalez, Ph.D., Allison R. McMullen, Ph.D., Meghan A. Wallace, B.S., Matthew P. Crotty, Pharm.D., David J. Ritchie, Pharm.D., and Carey-Ann D. Burnham, Ph.D. Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Washington University School of Medicine, St. Louis, MO; Department of Laboratory Medicine, Children’s Healthcare of Atlanta, Atlanta, GA; Pharmacy Department, Barnes-Jewish Hospital, St. Louis, MO; Department of Pharmacy, Methodist Dallas Medical Center, Dallas, TX; Pharmacy Practice Department, St. Louis College of Pharmacy, St. Louis, MO, USA

Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria